US Government Backs In Vivo Cell Therapy Startup with Major Funding
The US government recently awarded up to $40.7 million in federal funding to immunoVec, a Los Angeles-based startup, following its debut on October 8, 20255.
Funding is specifically directed at in vivo cell therapy research, an emerging field distinct from traditional ex vivo cell therapy approaches5.
This investment is part of a broader federal push to support advanced biotechnologies, reflecting heightened interest in next-generation medical treatments.